Clinical Trial

Characterization of Cerebral Tau Aggregates With 18F-RO6958948 PET in the ALFA Population

Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated May 31, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study will characterize tau tracer retention by Positron Emission Tomography (PET) as a function of amyloid levels transversally and longitudinally.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2020-07-20; most recent amendment 2025-05-27.
Trial Details
NCT Number NCT04482660
Lead Sponsor Barcelonabeta Brain Research Center, Pasqual Maragall Foundation
Collaborators: Hoffmann-La Roche, Hospital Clinic of Barcelona
Conditions Healthy, Mild Cognitive Impairment
Enrollment 100 participants
Start Date 2021-03-29
Primary Completion 2025-12-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-05-31